.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 6,863,891

« Back to Dashboard

Summary for Patent: 6,863,891

Title: Oligopeptide lyophilisate, their preparation and use
Abstract:A novel lyophilizate and method of preparation as well as the use of the lyophilizate to treat female infertility and for gonad protection. Cetrorelix is dissolved in acetic acid 30% v/v, the solution is transferred to water and freeze dried.
Inventor(s): Engel; Jurgen (Alzenau, DE), Wichert; Burkhard (Bielefeld, DE), Sauerbier; Dieter (Werter, DE), Reissmann; Thomas (Frankfurt am Main, DE)
Assignee: Zentaris AG (Frankfurt, DE)
Application Number:10/040,457
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent Metrics:
Source: PatentQuant.com
Field: Not categorized
Back Citations: 43rd percentile
Forward Citations: 0th percentile
Patent PDF download available with subscription

No matches for this query

Foreign Priority and PCT Information for Patent: 6,863,891

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany43 05 225Feb 19, 1993

International Patent Family for Patent: 6,863,891

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office0947200<disabled in preview>
Spain2148247<disabled in preview>
Finland940779<disabled in preview>
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc